SCTCi039-A-1

R201C

The cell line is not validated yet.

General

Cell Line

hPSCreg name SCTCi039-A-1
Cite as:
SCTCi039-A-1
Alternative name(s)
R201C
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 28th July 2025
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Radboudumc Stem Cell Technology Center (SCTC)
Owner VIB - Center for Molecular Neurology (VIBCMN)
Distributors
Derivation country Belgium

External Databases

BioSamples SAMEA118790079

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • DEE7
  • EIEE7
  • KCNQ2-NEE
  • KCNQ2-related epileptic encephalopathy
  • KCNQ2-related neonatal epileptic encephalopathy
  • developmental and epileptic encephalopathy 7
  • epileptic encephalopathy, early infantile, 7
  • epileptic encephalopathy, early infantile, type 7
  • KCNQ2-related disorders
show more synonyms
Genetic variants
KCNQ2 (target)
20q13
NM_172107.4:c.601C>T
NP_742105.1:p.Arg201Cys
Heterozygous

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA115428392

Ethics

Also have a look at the ethics information for the parental line SCTCi039-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

The source cell information can be found in the parental cell line SCTCi039-A.

Reprogramming method

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
Yes
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
CO2 Concentration 5 %
Medium Essential 8™ Flex
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Marker Expressed
EOMES
Yes
Mesoderm
Ont Id: UBERON_0000926
Marker Expressed
Desmin
Yes
Ectoderm
Ont Id: UBERON_0000924
Marker Expressed
NESTIN
Yes

Microbiology / Virus Screening

Mycoplasma Negative

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage: 26

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
No

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • DEE7
  • EIEE7
  • KCNQ2-NEE
  • KCNQ2-related epileptic encephalopathy
  • KCNQ2-related neonatal epileptic encephalopathy
  • developmental and epileptic encephalopathy 7
  • epileptic encephalopathy, early infantile, 7
  • epileptic encephalopathy, early infantile, type 7
  • KCNQ2-related disorders
show more synonyms
Genetic modifications
Isogenic modification
NM_172107.4:c.601T>C
NP_742105.1:p.Cys201Arg
Homozygous
Repaired